Cargando…

Biotechnologically Engineered Plants

SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Zareen, Glick, Bernard R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135915/
https://www.ncbi.nlm.nih.gov/pubmed/37106801
http://dx.doi.org/10.3390/biology12040601
_version_ 1785032094555045888
author Narayanan, Zareen
Glick, Bernard R.
author_facet Narayanan, Zareen
Glick, Bernard R.
author_sort Narayanan, Zareen
collection PubMed
description SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants capable of producing valuable biotechnological compounds. The development of plant-based biomanufacturing could offer a more sustainable and cost-effective method to produce useful products compared to traditional manufacturing process. ABSTRACT: The development of recombinant DNA technology during the past thirty years has enabled scientists to isolate, characterize, and manipulate a myriad of different animal, bacterial, and plant genes. This has, in turn, led to the commercialization of hundreds of useful products that have significantly improved human health and well-being. Commercially, these products have been mostly produced in bacterial, fungal, or animal cells grown in culture. More recently, scientists have begun to develop a wide range of transgenic plants that produce numerous useful compounds. The perceived advantage of producing foreign compounds in plants is that compared to other methods of producing these compounds, plants seemingly provide a much less expensive means of production. A few plant-produced compounds are already commercially available; however, many more are in the production pipeline.
format Online
Article
Text
id pubmed-10135915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101359152023-04-28 Biotechnologically Engineered Plants Narayanan, Zareen Glick, Bernard R. Biology (Basel) Review SIMPLE SUMMARY: Scientists are exploring the use of new genetic tools to engineer crop varieties which can result in desirable traits such as improved yield, disease resistance, and enhanced nutritional value. By manipulating the plants’ genetic makeup, they are able to develop transgenic plants capable of producing valuable biotechnological compounds. The development of plant-based biomanufacturing could offer a more sustainable and cost-effective method to produce useful products compared to traditional manufacturing process. ABSTRACT: The development of recombinant DNA technology during the past thirty years has enabled scientists to isolate, characterize, and manipulate a myriad of different animal, bacterial, and plant genes. This has, in turn, led to the commercialization of hundreds of useful products that have significantly improved human health and well-being. Commercially, these products have been mostly produced in bacterial, fungal, or animal cells grown in culture. More recently, scientists have begun to develop a wide range of transgenic plants that produce numerous useful compounds. The perceived advantage of producing foreign compounds in plants is that compared to other methods of producing these compounds, plants seemingly provide a much less expensive means of production. A few plant-produced compounds are already commercially available; however, many more are in the production pipeline. MDPI 2023-04-15 /pmc/articles/PMC10135915/ /pubmed/37106801 http://dx.doi.org/10.3390/biology12040601 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Narayanan, Zareen
Glick, Bernard R.
Biotechnologically Engineered Plants
title Biotechnologically Engineered Plants
title_full Biotechnologically Engineered Plants
title_fullStr Biotechnologically Engineered Plants
title_full_unstemmed Biotechnologically Engineered Plants
title_short Biotechnologically Engineered Plants
title_sort biotechnologically engineered plants
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135915/
https://www.ncbi.nlm.nih.gov/pubmed/37106801
http://dx.doi.org/10.3390/biology12040601
work_keys_str_mv AT narayananzareen biotechnologicallyengineeredplants
AT glickbernardr biotechnologicallyengineeredplants